Teva Pharma (TEVA) Needs to Raise Mylan (MYL) Bid to $85-$88/Share, Leerink Partners Says
Tweet Send to a Friend
Leerink Partners analyst Jason Gerberry weighed on Teva Pharma (NYSE: TEVA) after the company announced an unsolicited $82/share offer for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
